Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201306042 Principal Investigator: Tran, David
Title: A Phase II Study of the NovoTTF-100A System, Enhanced by Genomic Analysis to Identify the Genetic Signature of Response in the Treatment of Recurrent Glioblastoma Multiforme
Phase: II Disease Site: Brain & Nervous System
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to redefine how efficacy of the NovoTTF-100A device is determined by performing whole exome and RNA sequencing to identify the genomic signature of patients who respond to treatment.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)